SophieLeff

Associate

New York + 1.212.326.3406

Connect:

Share

Sophie Leff focuses her practice on civil litigation in the health care and life sciences sectors. She defends health care and life sciences clients in investigations and litigation brought by federal agencies and qui tam whistleblowers under the False Claims Act (FCA) and similar fraud and abuse laws. Sophie also counsels health systems, provider networks, medical device manufacturers, and digital health and health technology companies on regulatory and compliance matters.

Sophie maintains an active pro bono practice. She works with the Firm's Anti-Human Trafficking Task Force to raise awareness about and mitigate human trafficking-related risks in corporate and health care supply chains. She also represents clients seeking a variety of immigration relief at the trial and appellate levels. Additionally, Sophie works on pro bono criminal appeals and habeas cases.

Sophie serves as an assistant professorial lecturer in law at George Washington University Law School, where she teaches a law school preparation course for incoming law students.

Experience

  • Diebold Nixdorf successfully restructures over $2.7 billion in funded debt and completes the first-ever dual proceeding under the U.S. bankruptcy code and Dutch restructuring law in 71 daysIn the first-ever cross border restructuring involving dual main proceedings under chapter 11 of the U.S. Bankruptcy Code and a scheme of arrangement (the "Dutch Scheme") under the Dutch Act on Confirmation of Extrajudicial Plans (Wet Homologatie Onderhands Akkoord ("WHOA")), and the first-ever chapter 15 recognition of Dutch Scheme proceedings and a sanctioned WHOA reorganization plan (the "WHOA Plan"), Jones Day represented Diebold Nixdorf, Incorporated ("Diebold") and certain of its U.S. and Canadian subsidiaries (the "Debtors") in connection with (i) the prepackaged chapter 11 cases of In re Diebold Holding Company, LLC, et al., (Case No. 23-90602-DRJ) commenced on June 1, 2023, in the United States Bankruptcy Court for the Southern District of Texas (the "Bankruptcy Court"); (ii) the Dutch Scheme, commenced on June 1, 2023 by Diebold Nixdorf Dutch Holding B.V. (the "Dutch Issuer") in the District Court of Amsterdam (the "Dutch Court"), and (iii) the chapter 15 proceedings before the Bankruptcy Court commenced by the foreign representative of the Dutch Issuer, wherein the Bankruptcy Court recognized the Dutch Scheme proceeding as a foreign main proceeding and recognized and extended comity to the WHOA Plan that was sanctioned by the Dutch Court.
    • View All

    April 2024 White Paper

    2023 False Claims Act Enforcement in Health Care and Life Sciences, Part II

    March 2024 White Paper

    2023 False Claims Act Enforcement in Health Care and Life Sciences, Part I

    July 2023 White Paper

    Companies to Navigate Complex and Changing Requirements Focused on Combatting Forced Labor in Supply Chains

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.